CME Information

Course Overview Program Director Educational Objectives

Target Audience Method of Participation Accreditation Statement Term of Approval

Peer Review Disclaimer Disclosure Acknowledgement of Support

Course Overview

A woman’s beliefs, attitudes and values are shaped by the culture in which she is raised and by the most influential of those with whom she interacts as she matures - her immediate and extended family members, her teachers, her friends, her sexual partners, her workplace, and her church community. That process, called acculturation, continues as she is exposed to and adapts or borrows the traits of another culture. This monograph explores how the values and beliefs inherent in a woman’s cultural upbringing influence her attitudes regarding contraceptive appropriateness, and how these beliefs can affect her ability to receive optimal contraceptive care.

The goal of this monograph is to familiarize clinicians with prevalent cultural attitudes that may create barriers to contraceptive use and to encourage the development of cultural competency to enhance the effectiveness of patient interactions. It is by no means exhaustive but is meant to provide an overview of key issues and resources that may help clinicians enhance their awareness of cultural differences and their development of “cultural competency.”

Educational Objectives

At the conclusion of this activity, the participant should be able to:

• Articulate universally shared cultural perceptions regarding gender roles and reproductive issues

• Describe specific cultural attitudes in Hispanics/Latinos and African Americans, the two largest ethnic populations in the United States

• Describe the common religious beliefs that impact contraceptive use

• Identify some resources for communicating effectively with patients of different cultures, including educational tools to gauge clinicians’ cultural competence and to clarify misconceptions related to contraceptive methods

Target Audience

back to top

This CME activity is designed to meet the educational needs of obstetricians, gynecologists, family medicine physicians, general practitioners, residents, nurse practitioners, physician assistants, and other practitioners who wish to expand their understanding of cultural differences that may influence a woman’s perception of contraceptive appropriateness.

Method of Participation

This activity is a monograph in portable document format (PDF). References are linked to PubMed abstracts.

To receive a maximum of 1.0 AMA PRA Category 1 Credit(s)™ you should:

• View the presentations in this CME activity and evaluate the content presented

• Complete and submit the posttest, CME registration and activity evaluation forms

The estimated time to complete this activity, including review of the materials, is 1.0 hour(s).

Accreditation/Credit Designation

back to top

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baylor College of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.    

ACCME accredited providers may issue credit to both U.S. and international physicians for any activity that has been designated for AMA PRA Category 1 Credit(s)™ in accordance with PRA requirements.

Term of Approval

August 2007 through August 2008. Original release date: August 2007

Peer Review

back to top

In July 2007, this continuing medical education activity was peer reviewed by Paula Amato, MD, associate professor, Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon. In order to ensure the continued scientific relevance of this enduring material, it will be reviewed again in August 2008.

Disclosure: Nothing to disclose

Program Director

back to top

Paula Amato, MD
Associate Professor
Department of Obstetrics & Gynecology
Oregon Health & Science University
Portland, Oregon

Disclosure: nothing to disclose.

Alfred N. Poindexter, III, MD
Professor, Department of Obstetrics and Gynecology
Director, Division of Contraceptive Research and Development
Director, Gynecological Services, Baylor Population Program
Baylor College of Medicine
Houston, Texas

Director of the Reproductive Endocrinology Service
University of Houston

Disclosure: non-public support of research – Duramed, Wyeth Pharmaceuticals, Warner Chilcott.

Disclaimer

This CME activity is designed for use by healthcare professionals for educational purposes only. Information and opinion offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.

Baylor College of Medicine makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Links are provided to other Internet sites solely for the convenience of users. Once you link to another site, you are subject to the site's terms and conditions of use including copyright and licensing restrictions.

Disclosure

back to top

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: l) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Alfred Poindexter, MD, Activity Director: non-public support of research – Duramed, Wyeth Labs, Warner Chilcott

The following individual(s) has/have reported no financial or other relationships with commercial entities whose products/services may relate to the educational content of this activity:

Paula Amato, MD, Activity Director and Peer Reviewer: nothing to disclose.

Paul D. Blumenthal, MD, MPH, Contributor: nothing to disclose.

Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with the applicable law.

Baylor College of Medicine requires that all contributors disclose an unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products, and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.

Acknowledgement of Support

This CME activity is supported by an educational grant from Wyeth Pharmaceuticals, Inc.

back to top